These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10549287)

  • 21. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product.
    Latour S; Gish G; Helgason CD; Humphries RK; Pawson T; Veillette A
    Nat Immunol; 2001 Aug; 2(8):681-90. PubMed ID: 11477403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP.
    Sayós J; Martín M; Chen A; Simarro M; Howie D; Morra M; Engel P; Terhorst C
    Blood; 2001 Jun; 97(12):3867-74. PubMed ID: 11389028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. XLP: one gene, many players.
    Czar MJ; Schwartzberg PL
    Clin Immunol; 2001 Jul; 100(1):2-3. PubMed ID: 11414739
    [No Abstract]   [Full Text] [Related]  

  • 24. The XLP syndrome protein SAP interacts with SH3 proteins to regulate T cell signaling and proliferation.
    Li C; Schibli D; Li SS
    Cell Signal; 2009 Jan; 21(1):111-9. PubMed ID: 18951976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus.
    Howie D; Sayos J; Terhorst C; Morra M
    Curr Opin Immunol; 2000 Aug; 12(4):474-8. PubMed ID: 10899030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation.
    Latour S; Roncagalli R; Chen R; Bakinowski M; Shi X; Schwartzberg PL; Davidson D; Veillette A
    Nat Cell Biol; 2003 Feb; 5(2):149-54. PubMed ID: 12545173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
    Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
    Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.
    Nagy N; Mattsson K; Maeda A; Liu A; Székely L; Klein E
    Immunol Lett; 2002 Jun; 82(1-2):141-7. PubMed ID: 12008045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural characterization of disease-causing mutations on SAP and the functional impact on the SLAM peptide: a molecular dynamics approach.
    Chandrasekaran P; Rajasekaran R
    Mol Biosyst; 2014 Jul; 10(7):1869-80. PubMed ID: 24770789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis and diagnosis of X-linked lymphoproliferative disease.
    Gilmour KC; Gaspar HB
    Expert Rev Mol Diagn; 2003 Sep; 3(5):549-61. PubMed ID: 14510176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
    Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
    Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between SAP and FynT: Inducible SH3 domain-mediated interaction controlled by engagement of the SLAM receptor.
    Chen R; Latour S; Shi X; Veillette A
    Mol Cell Biol; 2006 Aug; 26(15):5559-68. PubMed ID: 16847311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease.
    Wu C; Sayos J; Wang N; Howie D; Coyle A; Terhorst C
    Immunogenetics; 2000 Aug; 51(10):805-15. PubMed ID: 10970095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The X-linked lymphoproliferative disease gene product SAP associates with PAK-interacting exchange factor and participates in T cell activation.
    Gu C; Tangye SG; Sun X; Luo Y; Lin Z; Wu J
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14447-52. PubMed ID: 16983070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
    Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
    Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
    Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
    Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
    Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
    Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective.
    Gaspar HB; Sharifi R; Gilmour KC; Thrasher AJ
    Br J Haematol; 2002 Dec; 119(3):585-95. PubMed ID: 12437631
    [No Abstract]   [Full Text] [Related]  

  • 40. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.